Flagellin Stimulates Lung Innate Mucosal Immunity
鞭毛蛋白刺激肺先天粘膜免疫
基本信息
- 批准号:7917951
- 负责人:
- 金额:$ 43.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-01 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:AlveolarAnti-Bacterial AgentsAntimicrobial Cationic PeptidesBacteriaBacterial PneumoniaCellsComplicationDataDistantEpithelialEpithelial CellsFlagellinGram-Negative Aerobic BacteriaHost DefenseImmune responseImmunityInfectionLungMediatingModelingMorbidity - disease rateMucosal ImmunityMusMyeloid CellsNanotechnologyNatural ImmunityOrganismOutcomePatientsPeptidesPneumoniaPropertyPseudomonasPseudomonas aeruginosaReceptor SignalingRelative (related person)Respiratory Tract InfectionsRoleSignal PathwaySiteTLR4 geneTLR5 geneToll-like receptorsUnited StatesVirusalveolar epitheliumantimicrobial peptidebactericidecathelicidincathelicidin antimicrobial peptideinsightmacrophagemicrobialmortalitynovelnovel strategiespathogenpreventprotective effectpublic health relevanceresearch studyresponse
项目摘要
DESCRIPTION (provided by applicant): Bacterial pneumonia is a frequent and deadly complication in hospitalized patients. Pseudomonas aeruginosa (PA) is an aerobic gram-negative bacterium that is the second most common cause of pneumonia in hospitalized patients, with mortality ranging from 60-90% in mechanically ventilated with pneumonia due to PA pneumonia. Innate host responses to PA are initiated by selected toll like receptors (TLR), including TLR4, which recognizes LPS, and TLR5, which is activated by flagellin. Flagellin stimulates protective immunity against diverse microbial pathogens, including bacteria and viruses. We have recently found that flagellin is a major inducer of the cationic peptide cathelicidin related antimicrobial peptide (CRAMP). CRAMP exerts important bactericidal and immunomodulatory properties that may contribute to the protective effects of flagellin observed in both infectious and non-infectious models. The central hypothesis of this revised proposal is that Pseudomonas flagellin stimulates protective lung innate mucosal immunity, which is mediated, in part, by the induction of the cationic antimicrobial peptide CRAMP. The Specific Aims of the proposal are as follows: Specific Aim 1. Determine the role of the cationic antimicrobial peptide CRAMP in mucosal innate responses during PA pneumonia Specific Aim 2. Determine the mechanism of flagellin-induced stimulation of protective lung innate antibacterial immunity The studies proposed will provide important insights into the role of cathelicidins in lung antibacterial host defense, and may potentially identify novel approaches to stimulate lung mucosal immunity that can be used to prevent or treat pneumonia in hospitalized patients.
PUBLIC HEALTH RELEVANCE: Lung infection due to Pseudomonas aeruginosa continues to be a major cause of both morbidity and mortality in the United States. We have identified flagellin as a potent inducer of protective innate responses against this organism in experimental Pseudomonas pneumonia. Flagellin-induced protection is mediated, in part, by the antimicrobial peptide cathelicidin related antimicrobial peptide (CRAMP). The studies proposed in this application may identify novel means to prevent and possibly treat patients with respiratory tract infections due to P. aeruginosa.
描述(由申请人提供):细菌性肺炎是住院患者常见且致命的并发症。铜绿假单胞菌 (PA) 是一种需氧革兰氏阴性菌,是住院患者肺炎的第二常见原因,PA 肺炎引起的机械通气肺炎死亡率为 60-90%。宿主对 PA 的先天反应是由选定的 Toll 样受体 (TLR) 启动的,包括识别 LPS 的 TLR4 和由鞭毛蛋白激活的 TLR5。鞭毛蛋白可刺激针对多种微生物病原体(包括细菌和病毒)的保护性免疫力。我们最近发现鞭毛蛋白是阳离子肽抗菌素相关抗菌肽(CRAMP)的主要诱导剂。 CRAMP 具有重要的杀菌和免疫调节特性,可能有助于在感染性和非感染性模型中观察到的鞭毛蛋白的保护作用。该修订提案的中心假设是假单胞菌鞭毛蛋白刺激保护性肺先天粘膜免疫,这部分是通过诱导阳离子抗菌肽 CRAMP 介导的。该提案的具体目标如下: 具体目标 1. 确定阳离子抗菌肽 CRAMP 在 PA 肺炎期间粘膜先天反应中的作用 具体目标 2. 确定鞭毛蛋白诱导的保护性肺先天抗菌免疫刺激的机制 拟议的研究将为导管素在肺部抗菌宿主防御中的作用提供重要见解,并可能确定 刺激肺粘膜免疫的新方法,可用于预防或治疗住院患者的肺炎。
公共卫生相关性:铜绿假单胞菌引起的肺部感染仍然是美国发病率和死亡率的主要原因。我们已经确定鞭毛蛋白是实验性假单胞菌肺炎中针对这种生物体的保护性先天反应的有效诱导剂。鞭毛蛋白诱导的保护部分是由抗菌肽抗菌肽相关抗菌肽 (CRAMP) 介导的。本申请中提出的研究可能会确定预防并可能治疗铜绿假单胞菌呼吸道感染患者的新方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Theodore J. Standiford其他文献
Multiple Myeloma Complicated by Restrictive Cardiomyopathy and Cardiac Tamponade
- DOI:
10.1378/chest.103.3.946 - 发表时间:
1993-03-01 - 期刊:
- 影响因子:
- 作者:
Mark A. Mitchell;Mark D. Homeffer;Theodore J. Standiford - 通讯作者:
Theodore J. Standiford
Theodore J. Standiford的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Theodore J. Standiford', 18)}}的其他基金
2016 Biology of Acute Respiratory Infection Gordon Research Conference & Gordon Research Seminar
2016年急性呼吸道感染生物学戈登研究会议
- 批准号:
9121654 - 财政年份:2016
- 资助金额:
$ 43.02万 - 项目类别:
Novel IL-1 Family Members in Lung Innate Immunity
肺先天免疫中的新 IL-1 家族成员
- 批准号:
8885102 - 财政年份:2015
- 资助金额:
$ 43.02万 - 项目类别:
Novel IL-1 Family Members in Lung Innate Immunity
肺先天免疫中的新 IL-1 家族成员
- 批准号:
9032530 - 财政年份:2015
- 资助金额:
$ 43.02万 - 项目类别:
Flagellin Stimulates Lung Innate Mucosal Immunity
鞭毛蛋白刺激肺先天粘膜免疫
- 批准号:
8435549 - 财政年份:2010
- 资助金额:
$ 43.02万 - 项目类别:
Flagellin Stimulates Lung Innate Mucosal Immunity
鞭毛蛋白刺激肺先天粘膜免疫
- 批准号:
8212532 - 财政年份:2010
- 资助金额:
$ 43.02万 - 项目类别:
Flagellin Stimulates Lung Innate Mucosal Immunity
鞭毛蛋白刺激肺先天粘膜免疫
- 批准号:
8051783 - 财政年份:2010
- 资助金额:
$ 43.02万 - 项目类别:
A Randomized Trial of GM-CSF in Patients with ALI
GM-CSF 在 ALI 患者中的随机试验
- 批准号:
7213169 - 财政年份:2005
- 资助金额:
$ 43.02万 - 项目类别:
SCCOR in Translational Research in Acute Lung Injury
SCCOR 在急性肺损伤转化研究中的应用
- 批准号:
6673511 - 财政年份:2003
- 资助金额:
$ 43.02万 - 项目类别:
SCCOR in Translational Research in Acute Lung Injury
SCCOR 在急性肺损伤转化研究中的应用
- 批准号:
6923762 - 财政年份:2003
- 资助金额:
$ 43.02万 - 项目类别:
相似海外基金
New technologies for targeted delivery of anti-bacterial agents
抗菌药物靶向递送新技术
- 批准号:
1654774 - 财政年份:2015
- 资助金额:
$ 43.02万 - 项目类别:
Studentship
Targeting bacterial phosphatases for novel anti-bacterial agents.
针对细菌磷酸酶的新型抗菌剂。
- 批准号:
8416313 - 财政年份:2012
- 资助金额:
$ 43.02万 - 项目类别:
Targeting bacterial phosphatases for novel anti-bacterial agents.
针对细菌磷酸酶的新型抗菌剂。
- 批准号:
8298885 - 财政年份:2012
- 资助金额:
$ 43.02万 - 项目类别: